H. Yasuda

发表

IL-1 plays an important role in the bone metabolism under physiological conditions.

Y. Iwakura, N. Fujikado, Young-mi Lee, 2010, International immunology.

Dynamic visualization of RANKL and Th17-mediated osteoclast function.

Masaru Ishii, Kazuya Kikuchi, Ronald N Germain, 2013, The Journal of clinical investigation.

Disruption of NF‐κB1 prevents bone loss caused by mechanical unloading

K. Aoki, K. Ohya, E. Jimi, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

JMJD5, a Jumonji C (JmjC) Domain-containing Protein, Negatively Regulates Osteoclastogenesis by Facilitating NFATc1 Protein Degradation*

Yuuki Imai, S. Kato, A. Yokoyama, 2012, The Journal of Biological Chemistry.

Netrin‐4 derived from murine vascular endothelial cells inhibits osteoclast differentiation in vitro and prevents bone loss in vivo

Y. Okazaki, T. Okano, M. Yamato, 2014, FEBS letters.

Bif‐1/Endophilin B1/SH3GLB1 regulates bone homeostasis

K. Aoki, M. Matsuda, E. Jimi, 2019, Journal of cellular biochemistry.

LOX Fails to Substitute for RANKL in Osteoclastogenesis

H. Takayanagi, J. Penninger, T. Okamura, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

RANKL, a necessary chance for clinical application to osteoporosis and cancer-related bone diseases.

H. Yasuda, 2013, World journal of orthopedics.

A human alpha-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingers

T. Tamaoki, H. Yasuda, T. Morinaga, 1991, Molecular and cellular biology.

Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.

T. Martin, E. Jimi, N. Udagawa, 1999, Bone.

Bone Morphogenetic Protein 2 Stimulates Osteoclast Differentiation and Survival Supported by Receptor Activator of Nuclear Factor-κB Ligand.

N. Ueno, T. Martin, S. Iemura, 2001, Endocrinology.

Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor.

S. Mochizuki, H. Yasuda, M. Goto, 1998, Biochemical and biophysical research communications.

RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.

H. Yasuda, K. Yamaguchi, T. Morinaga, 1998, Biochemical and biophysical research communications.

Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.

T. Martin, N. Udagawa, N. Takahashi, 2000, Endocrinology.

Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis

H. Yasuda, A. Murakami, E. Tsuda, 2002, Journal of Bone and Mineral Metabolism.

The effect of switching from teriparatide to anti-RANKL antibody on cancellous and cortical bone in ovariectomized mice.

Y. Kadono, Sakae Tanaka, T. Miyamoto, 2018, Bone.

Peptide drugs accelerate BMP‐2‐induced calvarial bone regeneration and stimulate osteoblast differentiation through mTORC1 signaling

Y. Tabata, K. Aoki, R. Murali, 2016, BioEssays : news and reviews in molecular, cellular and developmental biology.

Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization

Y. Toyama, T. Suda, J. Penninger, 2011, The Journal of experimental medicine.

Accelerated cartilage resorption by chondroclasts during bone fracture healing in osteoprotegerin-deficient mice.

Y. Okada, Y. Toyama, M. Matsumoto, 2009, Endocrinology.

Regulation of RANKL-Induced Osteoclastogenesis by TGF-β

Sakae Tanaka, H. Yasuda, T. Yasui, 2013 .

Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis

N. Udagawa, T. Ninomiya, Midori Nakamura, 2017, PloS one.

Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice.

N. Udagawa, T. Ninomiya, Midori Nakamura, 2013, Endocrinology.

The local administration of TNF-α and RANKL antagonist peptide promotes BMP-2-induced bone formation

K. Aoki, K. Ohya, M. Mamun, 2013 .

Stimulation of Bone Formation in Cortical Bone of Mice Treated with a Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-binding Peptide That Possesses Osteoclastogenesis Inhibitory Activity

J. Penninger, K. Aoki, K. Ohya, 2013, The Journal of Biological Chemistry.

Evaluation of Pharmaceuticals With a Novel 50‐Hour Animal Model of Bone Loss

N. Udagawa, T. Ninomiya, Y. Nakamichi, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Evidence for the major contribution of remodeling-based bone formation in sclerostin-deficient mice.

N. Udagawa, T. Yamashita, Yasuhiro Kobayashi, 2022, Bone.

Sclerostin expression in trabecular bone is downregulated by osteoclasts

J. Penninger, N. Udagawa, T. Yamashita, 2020, Scientific Reports.

Individual and combining effects of anti-RANKL monoclonal antibody and teriparatide in ovariectomized mice

Y. Kadono, Sakae Tanaka, Takumi Matsumoto, 2015, Bone reports.

A novel inhibitor of NF-κB-inducing kinase prevents bone loss by inhibiting osteoclastic bone resorption in ovariectomized mice.

K. Aoki, M. Matsuda, E. Jimi, 2020, Bone.

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.

S. Mochizuki, H. Yasuda, M. Goto, 1998, Endocrinology.

Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor.

H. Yasuda, T. Morinaga, K. Higashio, 1998, European journal of biochemistry.

A deleted form of human hepatocyte growth factor stimulates hepatic lipogenesis and lipoprotein synthesis in rats.

H. Masunaga, A. Shiota, H. Yasuda, 2000, Pharmacological research.

Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats

E. Imai, A. Shiota, H. Yasuda, 1996, Hepatology.

Tetracyclines Convert the Osteoclastic-Differentiation Pathway of Progenitor Cells To Produce Dendritic Cell-like Cells

T. Mizoguchi, A. Muto, N. Udagawa, 2012, The Journal of Immunology.

A fibroblast-derived tumor cytotoxic factor/F-TCF (hepatocyte growth factor/HGF) has multiple functions in vitro.

M. Nagao, H. Yasuda, T. Morinaga, 1991, Cell biology international reports.

Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion

K. Matsuo, Y. Kuroda, H. Matsui, 2016, PloS one.

RelB-induced Expression of Cot, an MAP3K Family Member, Rescues RANKL-induced Osteoclastogenesis in Alymphoplasia Mice by Promoting NF-κB2 Processing by IKKα*

F. Weih, E. Jimi, K. Maki, 2014, The Journal of Biological Chemistry.

Identity of a tumor cytotoxic factor from human fibroblasts and hepatocyte growth factor.

M. Nagao, H. Yasuda, M. Goto, 1990, Biochemical and biophysical research communications.

Preventive effects of the deleted form of hepatocyte growth factor against various liver injuries.

E. Imai, H. Masunaga, A. Shiota, 1998, European journal of pharmacology.

Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts.

K. Miyake, T. Kunisada, H. Hemmi, 1998, Biochemical and biophysical research communications.

Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op/op mice

H. DeLuca, S. Kato, J. Penninger, 2012, Proceedings of the National Academy of Sciences.

Proposed standard nomenclature for new tumor necrosis factor members involved in the regulation of bone resorption. The American Society for Bone and Mineral Research President's Committee on Nomenclature.

J. Aubin, T. Martin, A. F. Stewart, 2000, Bone.

Kif1c regulates osteoclastic bone resorption as a downstream molecule of p130Cas

M. Matsuda, A. Mizokami, E. Jimi, 2019, Cell biochemistry and function.

Effects of the deleted form of hepatocyte growth factor on serum hyaluronate levels in rats with liver cirrhosis.

H. Masunaga, A. Shiota, H. Yasuda, 1998, The Journal of veterinary medical science.

Identification of an Alternatively Spliced Variant of Ca2+-promoted Ras Inactivator as a Possible Regulator of RANKL Shedding*

Y. Kadono, Kozo Nakamura, Sakae Tanaka, 2005, Journal of Biological Chemistry.

Processing of the NF‐κB2 precursor p100 to p52 is critical for RANKL‐induced osteoclast differentiation

K. Aoki, K. Ohya, F. Weih, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Amelioration of Disordered Hepatic Protein Synthesis by the Deleted Form of Hepatocyte Growth Factor in Models of Liver Failure in Rats

H. Masunaga, A. Shiota, H. Yasuda, 1996, The Journal of pharmacy and pharmacology.

The Actin-Binding Protein PPP1r18 Regulates Maturation, Actin Organization, and Bone Resorption Activity of Osteoclasts

R. Baron, E. Jimi, T. Takano-Yamamoto, 2017, Molecular and Cellular Biology.

Osteoclast differentiation by RANKL and OPG signaling pathways

N. Udagawa, T. Yamashita, Midori Nakamura, 2020, Journal of Bone and Mineral Metabolism.

The W9 peptide directly stimulates osteoblast differentiation via RANKL signaling

J. Penninger, T. Mizoguchi, N. Udagawa, 2017 .

Anti-RANKL antibody was approved for the treatment of osteoporosis in Japan.

H. Yasuda, 2013, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

Receptor Activator of NF-κB Ligand and Osteoprotegerin Regulate Proinflammatory Cytokine Production in Mice1

J. Penninger, K. Matsuo, Y. Takada, 2006, The Journal of Immunology.

Diphenylhydantoin Inhibits Osteoclast Differentiation and Function Through Suppression of NFATc1 Signaling

Hiroaki Nakamura, T. Mizoguchi, N. Udagawa, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Osteoblast-derived Laminin-332 is a novel negative regulator of osteoclastogenesis in bone microenvironments

A. Kukita, T. Kukita, T. Yamaza, 2017, Laboratory Investigation.

Cell-like Cells Progenitor Cells To Produce Dendritic Osteoclastic-Differentiation Pathway of Tetracyclines Convert the

N. Udagawa, Midori Nakamura, N. Takahashi, 2022 .

Daily administration of eldecalcitol (ED‐71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone

T. Mizoguchi, N. Udagawa, Y. Nakamichi, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Mineral Trioxide Aggregate Inhibits Osteoclastic Bone Resorption

E. Jimi, K. Maki, W. Masuda, 2011, Journal of dental research.

Mineral trioxide aggregate solution inhibits osteoclast differentiation through the maintenance of osteoprotegerin expression in osteoblasts.

E. Jimi, N. Udagawa, Midori Nakamura, 2011, Journal of biomedical materials research. Part A.

Effects of RANKL on the thymic medulla

Y. Takahama, H. Yasuda, T. Nitta, 2011, European journal of immunology.

Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts.

M. Kumegawa, T. Miyata, H. Yasuda, 1998, Biochemical and biophysical research communications.

The pivotal role of the alternative NF‐κB pathway in maintenance of basal bone homeostasis and osteoclastogenesis

K. Aoki, K. Ohya, F. Weih, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Cbp recruitment of Csk into lipid rafts is critical to c‐Src kinase activity and bone resorption in osteoclasts

T. Yoneda, M. Okada, F. Ikeda, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Synovial cells from a patient with rheumatoid arthritis produce osteoclastogenesis inhibitory factor/osteoprotegerin: reciprocal regulation of the production by inflammatory cytokines and basic fibroblast growth factor

H. Yasuda, K. Higashio, E. Tsuda, 2001, Journal of Bone and Mineral Metabolism.

Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization

T. Suda, J. Penninger, K. Miyamoto, 2011, The Journal of experimental medicine.

Porphyromonas gingivalis-derived Lysine Gingipain Enhances Osteoclast Differentiation Induced by Tumor Necrosis Factor-α and Interleukin-1β but Suppresses That by Interleukin-17A

K. Mishima, Y. Miyamoto, J. Potempa, 2014, The Journal of Biological Chemistry.

DEGRADATION OF IMPORTANCE OF PROTEOLYTIC Suppresses That by Interleukin-17 A : but β and Interleukin-1 α Factor-Differentiation Induced by Tumor Necrosis Gingipain Enhances Osteoclast-derived Lysine

Toshifumi, K. Mishima, Y. Miyamoto, 2014 .

Fluorescent Imaging Techniques of Osteoclast Precursors Tracked by Using Systemic Circulation and Bone Recruitment

Manato Kotani, M. Ishii, F. Klauschen, 2012 .

Yeast Thioredoxin-Enriched Extracts for Mitigating the Allergenicity of Foods

H. Masutani, J. Yodoi, S. Furukawa, 2011, Bioscience, biotechnology, and biochemistry.

Bone Formation Is Coupled to Resorption Via Suppression of Sclerostin Expression by Osteoclasts

N. Udagawa, T. Yamashita, Midori Nakamura, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

ATBF1, a multiple-homeodomain zinc finger protein, selectively down-regulates AT-rich elements of the human alpha-fetoprotein gene

T. Tamaoki, H. Yasuda, T. Morinaga, 1994, Molecular and cellular biology.

Structure of the mouse osteoclastogenesis inhibitory factor (OCIF) gene and its expression in embryogenesis.

H. Yasuda, A. Murakami, T. Morinaga, 1998, Gene.

Deleted form of hepatocyte growth factor (dHGF) increases the number of platelets in rats with liver cirrhosis.

H. Masunaga, A. Shiota, H. Yasuda, 2008, Liver.

Tyrosine Kinases Btk and Tec Regulate Osteoclast Differentiation by Linking RANK and ITAM Signals

T. Kodama, R. Geha, T. Morio, 2008, Cell.

Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.

N. Ueno, T. Martin, S. Iemura, 2001, Endocrinology.

Interleukin‐4 inhibition of osteoclast differentiation is stronger than that of interleukin‐13 and they are equivalent for induction of osteoprotegerin production from osteoblasts

Y. Nakamichi, Y. Miyamoto, R. Kamijo, 2007, Immunology.

Induction of chondrogenesis with a RANKL-binding peptide, WP9QY, in vitro and in vivo in a rabbit model

Hiroaki Nakamura, S. Wakitani, H. Yasuda, 2022, Biochemical and Biophysical Research Communications.

Tumor Necrosis Factor (cid:97) Stimulates Osteoclast Differentiation by a Mechanism Independent of the ODF/RANKL–RANK Interaction

T. Martin, E. Jimi, N. Udagawa, 2022 .

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

K Yano, N. Udagawa, N. Takahashi, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Increased bone mass in mice after single injection of anti-receptor activator of nuclear factor-kappaB ligand-neutralizing antibody: evidence for bone anabolic effect of parathyroid hormone in mice with few osteoclasts.

Sakae Tanaka, N. Udagawa, T. Ninomiya, 2011, The Journal of biological chemistry.

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.

S. Mochizuki, H. Yasuda, M. Goto, 1998, Endocrinology.

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.

K Yano, S. Mochizuki, N. Amizuka, 1998, Biochemical and biophysical research communications.

Basic fibroblast growth factor inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D(3) through suppressing the production of osteoclast differentiation factor.

S. Mochizuki, H. Yasuda, K. Yamaguchi, 1999, Biochemical and biophysical research communications.

Historically significant events in the discovery of RANK/ RANKL/OPG

H. Yasuda, 2013 .

Transforming Growth Factor β Affects Osteoclast Differentiation via Direct and Indirect Actions

Hisataka Yasuda, Kanji Higashio, Naoyuki Takahashi, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Control of mammary stem cell function by steroid hormone signalling

J. Visvader, G. Smyth, T. Martin, 2010, Nature.

The thymic cortical epithelium determines the TCR repertoire of IL‐17‐producing γδT cells

H. Takayanagi, Yukiko Shimizu, T. Okamura, 2015, EMBO reports.

Stochastic differentiation into an osteoclast lineage from cloned macrophage-like cells.

K. Okuyama, S. Hayashi, H. Yasuda, 2012, Biochemical and biophysical research communications.

The Vitamin D Receptor in Osteoblast-Lineage Cells Is Essential for the Proresorptive Activity of 1α,25(OH)2D3 In Vivo

Yoko Yamamoto, S. Kato, N. Udagawa, 2020, Endocrinology.

Increased Bone Mass in Mice after Single Injection of Anti-receptor Activator of Nuclear Factor-κB Ligand-neutralizing Antibody

Sakae Tanaka, N. Udagawa, T. Ninomiya, 2011, The Journal of Biological Chemistry.

Genomewide Comprehensive Analysis Reveals Critical Cooperation Between Smad and c‐Fos in RANKL‐Induced Osteoclastogenesis

H. Aburatani, Y. Kadono, Sakae Tanaka, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

A novel molecular mechanism modulating osteoclast differentiation and function.

N. Udagawa, N. Takahashi, S. Mochizuki, 1999, Bone.

Hepatocyte apoptosis and hepatic expression of transforming growth factor‐β1 mRNA during involution of hyperplastic rat liver induced by hepatocyte growth factor

K. Fujiwara, F. Yamanobe, A. Ohno, 1998, Journal of gastroenterology and hepatology.

Regulation of RANKL‐induced osteoclastogenesis by TGF‐β through molecular interaction between Smad3 and Traf6

Y. Kadono, Kozo Nakamura, Sakae Tanaka, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone resorption facilitates osteoblastic bone metastatic colonization by cooperation of insulin-like growth factor and hypoxia

S. Kizaka-Kondoh, T. Kuchimaru, T. Kadonosono, 2014, Cancer science.

Discovery of the RANKL/RANK/OPG system

H. Yasuda, 2021, Journal of Bone and Mineral Metabolism.

The Fractalkine‐CX3CR1 Axis Regulates Non‐inflammatory Osteoclastogenesis by Enhancing Precursor Cell Survival

K. Matsuo, Y. Kuroda, T. Imai, 2022, JBMR plus.

Transcriptionally active nuclei are selective in mature multinucleated osteoclasts

Yuuki Imai, S. Kato, H. Yasuda, 2010, Genes to cells : devoted to molecular & cellular mechanisms.

Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures.

N. Udagawa, N. Takahashi, T. Suda, 1998, Biochemical and biophysical research communications.

p130Cas, Crk‐Associated Substrate, Plays Important Roles in Osteoclastic Bone Resorption

S. Kato, K. Aoki, K. Ohya, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Cloning and characterization of the gene encoding mouse osteoclast differentiation factor.

M. Ueda, H. Yasuda, A. Murakami, 1999, Gene.

Induction of Osteoclast Differentiation by Runx2 through Receptor Activator of Nuclear Factor-κB Ligand (RANKL) and Osteoprotegerin Regulation and Partial Rescue of Osteoclastogenesis in Runx2–/– Mice by RANKL Transgene*

R. Fukuyama, N. Kanatani, C. Yoshida, 2003, Journal of Biological Chemistry.

Development of a conventional immunochemical detection system for determination of Nδ-(5-hydro-5-methyl-4-imidazolone-2-yl)-ornithine in methylglyoxal-modified proteins

R. Nagai, M. Nagai, H. Yasuda, 2020, Glycoconjugate Journal.

RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer.

K. Sakamoto, K. Omura, A. Yamaguchi, 2013, The American journal of pathology.

Identification of embryonic precursor cells that differentiate into thymic epithelial cells expressing autoimmune regulator

S. Yagi, Guoying Wu, J. Penninger, 2016, The Journal of experimental medicine.

Establishment of a new murine model of hypercalcemia with anorexia by overexpression of soluble receptor activator of NF-κB ligand using an adenovirus vector

J. Miyazaki, H. Yasuda, Y. Furuya, 2011, Journal of Bone and Mineral Metabolism.

Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone.

N. Udagawa, S. Mochizuki, T. Suda, 1998, Biochemical and biophysical research communications.

Purification and identification of estrogen receptor alpha co‐regulators in osteoclasts

Yuuki Imai, S. Kato, H. Yasuda, 2010, Annals of the New York Academy of Sciences.

Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment

J. Penninger, T. Mizoguchi, N. Udagawa, 2012, Journal of Cell Science.

Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells.

S. Mochizuki, H. Yasuda, D. Chikazu, 1999, Biochemical and biophysical research communications.

Correction to: Discovery of the RANKL/RANK/OPG system

H. Yasuda, 2021, Journal of Bone and Mineral Metabolism.

Sclerostin deficiency effectively promotes bone morphogenetic protein-2-induced ectopic bone formation.

N. Udagawa, T. Yamashita, Yasuhiro Kobayashi, 2023, Journal of periodontal research.

Systemic Circulation and Bone Recruitment of Osteoclast Precursors Tracked by Using Fluorescent Imaging Techniques

A. Miyawaki, Manato Kotani, M. Ishii, 2013, The Journal of Immunology.

The vitamin D receptor in osteoblastic cells but not secreted parathyroid hormone is crucial for soft tissue calcification induced by the proresorptive activity of 1,25(OH)2D3

N. Udagawa, Y. Nakamichi, N. Takahashi, 2023, Journal of Steroid Biochemistry and Molecular Biology.

Establishment of a xenograft model to explore the mechanism of bone destruction by human oral cancers and its application to analysis of role of RANKL.

K. Sakamoto, A. Yamaguchi, H. Yasuda, 2016, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Development of a method for the identification of receptor activator of nuclear factor-κB+ populations in vivo.

T. Mizoguchi, A. Katakura, H. Yasuda, 2021, Journal of oral biosciences.

[Bone and bone related biochemical examinations. Bone and collagen related metabolites. Receptor activator of NF-kappaB ligand (RANKL)].

H. Yasuda, 2006, Clinical calcium.

The vitamin D receptor in osteoblastic cells but not secreted parathyroid hormone is crucial for soft tissue calcification induced by the proresorptive activity of 1,25(OH)2D3

N. Udagawa, N. Takahashi, H. Yasuda, 2023, The Journal of Steroid Biochemistry and Molecular Biology.

Dynamic visualization of RANKL and Th17-mediated osteoclast function.

M. Ishii, R. Germain, K. Kikuchi, 2013, The Journal of clinical investigation.